Teva Pharmaceutical Industries

NYSE TEVA
$18.48 -0.28 -1.49%
Today share price
Israel
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 21.25 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
17.81B
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
32.77B
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.87
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
1.16B
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-16.15 %

Upcoming events Teva Pharmaceutical Industries

All events
No upcoming events scheduled

Stock chart Teva Pharmaceutical Industries

Stock analysis Teva Pharmaceutical Industries

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-13.86 15.60
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
4.63 2.76
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
22.07 10.61
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
10.07 1.76
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-20.52 17.95

Price change Teva Pharmaceutical Industries per year

12.82$ 22.77$
Min Max

Summary analysis Teva Pharmaceutical Industries

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Teva Pharmaceutical Industries

Revenue and net income Teva Pharmaceutical Industries

All parameters

About company Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell S.A. to develop mdc-IRM, a risperidone extended-release injectable suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel.
Address:
124 Dvora Hanevi?a Street, Tel Aviv, Israel, 6944020
Company name: Teva Pharmaceutical Industries
Issuer ticker: TEVA
ISIN: US8816242098
Country: Israel
Exchange: NYSE
Currency: $
IPO date: 1990-03-26
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.tevapharm.com